Translational Development Acquisition (TDACW) Other Non Operating Income (2024 - 2026)

Translational Development Acquisition (TDACW) has reported Other Non Operating Income for 3 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non Operating Income fell 10.86% year-over-year to $1.6 million; the trailing twelve-month figure through Jun 2026 stood at $6.8 million (up 78.01% YoY), and the FY2025 full-year result was $7.3 million, up 5729.44% from the prior year.
• Other Non Operating Income grew to $1.6 million in Q2 2026 per TDACW's latest filing, from $1.6 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $1.9 million in Q3 2025 and bottomed at $125346.0 in Q4 2024.
• Historically, Other Non Operating Income has averaged $1.5 million across 3 years, with a median of $1.6 million in 2026.
• The sharpest annual moves came in 2025 and 2026: Other Non Operating Income jumped 1202.7% in 2025, then retreated 11.83% in 2026.
• Over 3 years, Other Non Operating Income stood at $125346.0 in 2024, then surged by 1202.7% to $1.6 million in 2025, then gained by 0.69% to $1.6 million in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $1.6 million, $1.6 million, and $1.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.